BBIO

BridgeBio Pharma, Inc. BBIO

$81.38 +1.08 (+1.34%)

Extended · +1.06σ

+ Compare Open in Sniper

Mkt cap $15.9B

P/E —

Day $78.98 – $82.56

52wk $62.50 – $93.42

Avg vol —

Beta —

Div yld —

Next earnings —

Quick read

Plain English

BridgeBio Pharma, Inc. is a healthcare company listed in the US.

BBIO last traded at $81.38, up 1.3% on the day; that's in the middle part of its 52-week range ($62.50–$93.42). Right now it's trading above its recent average — momentum is positive, though some of the move may already be in the price.

Earnings reports are the biggest scheduled catalysts to keep an eye on, and after a strong run, watch whether the price can hold its gains on quieter days.

A plain-English snapshot built from the data on this page — not investment advice. Always do your own research.

132-Day Trend Zones

Full chart →

21 EMA +1 ATR +2 ATR −2 ATR

—

O — H — L — C —

— —

Valuation & accounting

Valuation desk →

The model's verdict is “Unknown” and accounting quality screens as Weak. Model estimates only — do your own due diligence.

Fair-value range

$7.69 – $7.69

Verdict

Unknown

Accounting quality Weak

✓ Quick ratio 3.75 (antifragile)
✓ Current ratio 2.77 (antifragile)
✓ Gross margin 95% (pricing power)

⚠ Debt exceeds cash
⚠ Negative retained earnings
⚠ Receivables growing faster than revenue
⚠ Stock comp 26% of revenue (heavy dilution)

Key statistics

All statistics →

BBIO is a $15.9 billion company.

Mkt cap $15.9B

P/E ttm —

Fwd P/E —

Beta —

Day range $78.98 – $82.56

52w range $62.50 – $93.42

Avg vol —

RSI(2) 43.1

ROE —

Net mgn —

FCF mgn -63.3%

Debt/Eq —

Div yld —

Sector Healthcare

Industry Biotechnology

Next earn —

52-week range · today's price

$62.50$93.42